Cargando…
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
The antitumor response after therapeutic vaccination has a limited effect and seems to be related to the presence of T regulatory cells (Treg), which express the immunoregulatory molecules CTLA4 and Foxp3. The blockage of CTLA4 using antibodies has shown an effective antitumor response conducing to...
Autores principales: | Miguel, Antonio, Sendra, Luis, Noé, Verónica, Ciudad, Carles J, Dasí, Francisco, Hervas, David, Herrero, María José, Aliño, Salvador F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271385/ https://www.ncbi.nlm.nih.gov/pubmed/28176947 http://dx.doi.org/10.2147/OTT.S104393 |
Ejemplares similares
-
Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model
por: Miguel, Antonio, et al.
Publicado: (2012) -
Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
por: Miguel, Antonio, et al.
Publicado: (2014) -
Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii
por: Batista-Duharte, Alexander, et al.
Publicado: (2021) -
Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts
por: Liu, Sisi, et al.
Publicado: (2020) -
An update on GM-CSF and its potential role in melanoma management
por: O Dillman, Robert
Publicado: (2020)